Abstracts
Showing 850 abstracts.
Citation
Rupak Shivakoti, Mark Giganti, Michael Lederman, Rachel Ketchum, Sean Brummel, Daniela Moisi, Sufia Dadabhai, Daya Moodley, Avy Violari, Lameck Chinula, Maxensia Owor, Amita Gupta, Judith S. Currier, Taha E Taha, Mary Glenn Fowler, PROMISE study team. Systemic inflammation in pregnant women with HIV: relationship with preterm delivery and HIV treatment regimen. Presented at: International Workshop on HIV Pediatrics; 2023 Jul 24.Conference
International Workshop on HIV Pediatrics
Study
1077BF
Citation
Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Phillippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 Study Team. Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trial. Presented at: International Workshop on HIV Pediatrics.Conference
International Workshop on HIV Pediatrics
Study
P1078
Citation
Jeremiah Momper, Hardik Chandasana, Benjamin Johnston, Hannah Small, David Shapiro, Jiajia Wang, Evan Goldberg, Sarah Bradford, Iris Mustich, Haley Brozik, Dwight Yin, Ellen Townley, Kelly Colsh, Andrea McMunn, Gretchen Buckler, Annie Buchanan, Alicia Koblansky, Michael McKenna, Ceora Beijer, Helty Adisetiyo, Dean Soko, Mariam Aziz, Linda Aurpibul, Suchada Ruenglerdpong, Keswadee Lapphra, Kathleen Powis, Maria Letícia Cruz, Ed Acosta, Brookie Best, Mark Mirochnick, Diana Clarke. Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023). Presented at: International Workshop on HIV Pediatrics; 2024 Jul 20.Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2023
Citation
Kelong Han, Navin Goyal, Susan Ford, Amy Cheung, Lionel Tan, Cindy McCoig, Parul Patel, Edmund Capparelli, Brookie Best, Mark Marzinke, Conn Harrington, David Izard, Jenny Huang, Mark Baker. Selection of Cabotegravir Dosing Regimens for HIV Treatment and Pre-exposure Prophylaxis (PrEP) in Adolescents by Leveraging Adult Data. Presented at: International Workshop on HIV Pediatrics.Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2017
Citation
Michelle Bulterys, Kristin Baltrusaitis, Grace John-Stewart, Allen Matubu, Gerhard Theron, Mercy Mutambanengwe, Mary Glenn Fowler, PROMISE 1077BF/FF Team. Social Maternal Risk Factors Associated with Adverse Pregnancy Outcomes Among Women with HIV in the Multi-country IMPAACT PROMISE Trial. Presented at: International Workshop on HIV Pediatrics; 2026 Jul 24; Rio de Janeiro, Brazil.Conference
International Workshop on HIV Pediatrics
Study
1077BF, 1077FF
Conference Location
Rio de Janeiro, Brazil
Citation
Anna-Barbara Moscicki, M.D., Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Edward Handelsman, M.D., Julie A. Patterson, B.S., Alfred J. Saah, M.D., M.P.H., David Radley, M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Carlos A. Sattler, M.D., Myron Levin, M.D. Safety and immunogenicity of Gardasil in HIV-infected children. Presented at: 25th International Papillomavirus Conference.Conference
25th International Papillomavirus Conference
Study
P1047
Citation
Suad Kapetanovic, M.D., Lisa Aaron, Grace Montepiedra, Ph.D., Patricia Sirois, Ph.D., Kathleen Malee, Ph.D., Patricia A. Garvie, Ph.D., Sharon L. Nichols, Ph.D., Betsy Kammerer, Ph.D., John J. Farley, M.D., M.P.H., James M. Oleske, M.D., Mark Mintz, M.D., Paige L. Williams, Ph.D. Relationships between use of antipsychotics and changes in physical growth in children and adolescents with HIV. Presented at: American Psychiatric Association Annual Meeting.Conference
American Psychiatric Association Annual Meeting
Citation
Tim Roy Cressey, B.Sc., Ph.D., Nirun Vanprapar, M.D., M.Sc., Edmund Capparelli, Pharm.D., Wasana Prasitsuebsai, M.D., Linda Aurpibul, M.D., Petronella Muresan, M.S., Achara Eksaengsri, B.Pharm., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D., Ram Yogev, M.D., Kulkanya Chokephaibulkit, M.D. Preliminary Pharmacokinetics and Safety of a Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC) and Nevirapine (NVP) versus the Liquid Formulations in HIV-Infected Thai Children. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.Conference
10th Int'l Workshop on Clinical Pharmacology of HIV Therapy
Study
P1069
Citation
Jennifer R. King, Pharm.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., Bobbie L. Graham, B.S., Vincent J. Carey, Ph.D., Paula Britto, M.S., Patrick Jean-Philippe, M.D., Eric K. Stets, B.S., Edward P. Acosta, Pharm.D. Tenofovir pharmacokinetics across three tenofovir-based antiretroviral regimens in HIV-infected children and adolescents. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.Conference
10th Int'l Workshop on Clinical Pharmacology of HIV Therapy
Citation
Jennifer R. King, Pharm.D. Population pharmacokinetics of tenofovir in HIV-infected children and adolescents. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.Conference
10th Int'l Workshop on Clinical Pharmacology of HIV Therapy